Pathogenesis and clinical significance of liver injury in celiac disease
- PMID: 18496773
- DOI: 10.1007/s12016-008-8086-x
Pathogenesis and clinical significance of liver injury in celiac disease
Abstract
Abnormalities of liver function are one of the manifold extraintestinal manifestations of celiac disease. Although the spectrum of liver manifestations associated with celiac disease is particularly wide, two main forms of liver damage namely, cryptogenic and autoimmune, appear to be strictly related to gluten-sensitive enteropathy. The most frequent finding is represented by a cryptogenic hypertransaminasemia, observed in about a half of untreated celiac patients, as an expression of a mild liver dysfunction with a histological picture of nonspecific reactive hepatitis (celiac hepatitis) reverting to normal after 6-12 months of a strict gluten-free diet. In a few cases, when celiac disease is diagnosed, a more severe liver injury, characterized by a cryptogenic chronic hepatitis or liver cirrhosis, is present. In these patients, liver damage can still improve after a gluten-free diet institution. Moreover, a close association between celiac disease and autoimmune liver disorders has been widely demonstrated. Indeed, celiac disease has been found in 3-7% of patients with primary biliary cirrhosis, in 3-6% with autoimmune hepatitis, and in 2-3% with primary sclerosing cholangitis. Differently from cryptogenic liver injury, autoimmune liver dysfunction, found in celiac disease, does not usually improve after a gluten-free diet. Presently, it is difficult to establish if the two main kinds of liver injury found in celiac disease (cryptogenic and autoimmune) are discrete entities with a different pathogenesis or if they are an expression of the same disorder where genetic factors and the duration of gluten exposure may determine the severity and the pattern of liver injury.
Similar articles
-
Liver dysfunction in celiac disease.Minerva Med. 2008 Dec;99(6):619-29. Minerva Med. 2008. PMID: 19034259 Review.
-
Liver involvement in celiac disease.Indian J Pediatr. 2006 Sep;73(9):809-11. doi: 10.1007/BF02790391. Indian J Pediatr. 2006. PMID: 17006040 Review.
-
To screen or not to screen? Celiac antibodies in liver diseases.World J Gastroenterol. 2017 Feb 7;23(5):776-791. doi: 10.3748/wjg.v23.i5.776. World J Gastroenterol. 2017. PMID: 28223722 Free PMC article. Review.
-
Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms.Dig Liver Dis. 2016 Feb;48(2):112-9. doi: 10.1016/j.dld.2015.11.013. Epub 2015 Nov 24. Dig Liver Dis. 2016. PMID: 26711682 Review.
-
[Hepatic involvement in celiac disease].Gastroenterol Hepatol. 2008 Jan;31(1):25-8. doi: 10.1157/13114567. Gastroenterol Hepatol. 2008. PMID: 18218277 Review. Spanish.
Cited by
-
Celiac disease markers in patients with liver diseases: a single center large scale screening study.World J Gastroenterol. 2012 Nov 21;18(43):6255-62. doi: 10.3748/wjg.v18.i43.6255. World J Gastroenterol. 2012. PMID: 23180946 Free PMC article.
-
Celiac disease and autoimmunity: review and controversies.Curr Allergy Asthma Rep. 2013 Aug;13(4):347-53. doi: 10.1007/s11882-013-0352-1. Curr Allergy Asthma Rep. 2013. PMID: 23681421 Free PMC article. Review.
-
A machine learning tool for early identification of celiac disease autoimmunity.Sci Rep. 2024 Dec 28;14(1):30760. doi: 10.1038/s41598-024-80817-0. Sci Rep. 2024. PMID: 39730479 Free PMC article.
-
Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey.World J Pediatr. 2009 Nov;5(4):282-6. doi: 10.1007/s12519-009-0053-y. Epub 2009 Nov 13. World J Pediatr. 2009. PMID: 19911143
-
Liver involvement in pediatric celiac disease.World J Gastroenterol. 2015 May 21;21(19):5813-22. doi: 10.3748/wjg.v21.i19.5813. World J Gastroenterol. 2015. PMID: 26019445 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical